Recent advances in cancer neuroscience necessitate the systematic analysis of neural influences in cancer as potential therapeutic targets in oncology. Here we outline recommendations for future preclinical and translational research in this field.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Zahalka, A. H. & Frenette, P. S. Nat. Rev. Cancer 20, 143–157 (2020).
Arranz, L. et al. Nature 512, 78–81 (2014).
Ceyhan, G. O. et al. Gastroenterology 136, 177–186.e1 (2009).
Amit, M., Na’ara, S. & Gil, Z. Nat. Rev. Cancer 16, 399–408 (2016).
Demir, I. E., Friess, H. & Ceyhan, G. O. Nat. Rev. Gastroenterol. Hepatol. 12, 649–659 (2015).
Saloman, J. L., Cohen, J. A. & Kaplan, D. H. Curr. Opin. Neurobiol. 62, 60–67 (2020).
Kamiya, A. et al. Nat. Neurosci. 22, 1289–1305 (2019).
Mantyh, P. W. Nat. Rev. Neurosci. 7, 797–809 (2006).
Pastuła, A. et al. Stem Cells Int. 2016, 3710836 (2016).
Faber, C.L., Matsen, M.E., Meek, T.H., Krull, J.E. & Morton, G.J. J. Vis. Exp. (2020).
Smith-Edwards, K. M. et al. EGastroenterology 157, 522–536.e2 (2019).
Giladi, A. et al. Nat. Biotechnol. 38, 629–637 (2020).
Deborde, S. et al. J. Clin. Invest. 126, 1538–1554 (2016).
Burma, N. E., Leduc-Pessah, H., Fan, C. Y. & Trang, T. J. Neurosci. Res. 95, 1242–1256 (2017).
Bailey, J. J., Schirrmacher, R., Farrell, K. & Bernard-Gauthier, V. Expert Opin. Ther. Pat. 27, 831–849 (2017).
Acknowledgements
I.E.D. was awarded the ENIGMA Young Investigator Prize of the Society for Scientific Meetings in Biomedicine to organize the NIC meeting. We thank Society for Scientific Meetings in Biomedicine (Verein für wissenschaftliche Fachtagungen in der Biomedizin e.V./VWFB e.V; www.vwfb.de) and its chair, H. Augustin, for support. The meeting was also supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft DE2428/7-1) and the Fritz Thyssen Foundation (30.19.0.128MN). I.E.D. was also funded by the Deutsche Forschungsgemeinschaft (project ID 329628492–SFB 1321). M.M. is a New York Stem Cell Foundation Druckenmiller fellow and was supported by the EMBO European Commission FP7 (Marie Curie Actions; EMBOCOFUND2012, GA-2012-600394, ALTF 447-2014).
Author information
Authors and Affiliations
Consortia
Contributions
I.E.D. wrote the first draft of the manuscript and was the main organizer of The 1st Neural Influences in Cancer (NIC) International Think Tank Meeting, which took place 7–9 November 2019 in Heidelberg, Germany. C.M.R. generated the figures. All authors made substantial contribution to the meeting and to the generation of the consensus concepts as outlined here, and have read and agreed on the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
T.C.W. is a Consultant for Novo Nordisc and Glaxo SmithKline and is on the Scientific Advisory Board for Cygnal Therapeutics.
Rights and permissions
About this article
Cite this article
Demir, I.E., Mota Reyes, C., Alrawashdeh, W. et al. Future directions in preclinical and translational cancer neuroscience research. Nat Cancer 1, 1027–1031 (2020). https://doi.org/10.1038/s43018-020-00146-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-020-00146-9
This article is cited by
-
Insights and opportunities at the crossroads of cancer and neuroscience
Nature Cell Biology (2022)
-
The dark side of synaptic proteins in tumours
British Journal of Cancer (2022)
